Prostate Cancer in Transgender Women: Incidence, Etiopathogenesis, and Management Challenges
- 1 December 2017
- journal article
- review article
- Published by Elsevier BV in Urology
- Vol. 110, 166-171
- https://doi.org/10.1016/j.urology.2017.08.032
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Metastatic prostate cancer in transsexual diagnosed after three decades of estrogen therapy.Canadian Urological Association Journal, 2013
- A perspective on the role of estrogen in hormone-induced prostate carcinogenesisCancer Letters, 2013
- Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7International Journal of Transgenderism, 2012
- “Completely out-at-sea” with “two-gender medicine”: A qualitative analysis of physician-side barriers to providing healthcare for transgender patientsBMC Health Services Research, 2012
- Estrogen-Initiated Transformation of Prostate Epithelium Derived from Normal Human Prostate Stem-Progenitor CellsEndocrinology, 2011
- DETECTION OF PROSTATE CANCER FOLLOWING GENDER REASSIGNMENTBJU International, 2007
- Effect of increasing ratio of estrogen: Androgen on proliferation of normal human prostate stromal and epithelial cells, and the malignant cell line LNCaPThe Prostate, 2005
- Testosterone Replacement Therapy in Hypogonadal Men at High Risk for Prostate Cancer: Results of 1 Year of Treatment in Men With Prostatic Intraepithelial NeoplasiaJournal of Urology, 2003
- IS LOW SERUM FREE TESTOSTERONE A MARKER FOR HIGH GRADE PROSTATE CANCER?Journal of Urology, 2000
- Metastatic prostatic carcinoma in a male‐to‐female transsexualBJU International, 1998